MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-30-2023
Apollo Endosurgery Total Liabilities 2011-2026 | APEN
Annual Total Liabilities Apollo Endosurgery
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 77.6 M | 70.3 M | 70.7 M | 72.5 M | 45.6 M | 59.1 M | 59.7 M | 1.08 M | 5.14 M | 5.7 M | 12.2 M | 17.3 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 77.6 M | 1.08 M | 41.4 M |
Quarterly Total Liabilities Apollo Endosurgery
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 73.7 M | - | 70 M | 70.3 M | 71.2 M | 71.7 M | 71.3 M | 70.7 M | 70.7 M | 70.7 M | 70.7 M | 72.5 M | 72.5 M | 72.5 M | 72.5 M | 45.6 M | 45.6 M | 45.6 M | 45.6 M | 59.1 M | 59.1 M | 59.1 M | 59.1 M | 59.7 M | 59.7 M | 59.7 M | 59.7 M | 94 M | 1.08 M | 1.08 M | 1.08 M | 5.14 M | 5.14 M | 5.14 M | 5.14 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 94 M | 1.08 M | 41.7 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
2.36 B | $ 186.55 | 3.25 % | $ 14 B |  USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
AxoGen
AXGN
|
92.8 M | $ 34.35 | 2.63 % | $ 1.58 B | USA |
 |
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
2.79 B | $ 12.74 | 3.41 % | $ 1.72 B | USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
2.79 B | $ 292.85 | 1.72 % | $ 8.26 B | USA |
 |
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.59 | 1.2 % | $ 36.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
45.2 M | $ 3.23 | -2.86 % | $ 121 M |  France |
 |
Bruker Corporation
BRKR
|
3.99 B | $ 40.2 | 2.93 % | $ 5.99 K | USA |
 |
Boston Scientific Corporation
BSX
|
16.7 B | $ 64.08 | 1.43 % | $ 94.9 B | USA |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
69.7 M | $ 10.4 | 3.92 % | $ 294 M | USA |
 |
IRIDEX Corporation
IRIX
|
24.2 M | $ 1.03 | 0.1 % | $ 17.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
10.6 M | $ 25.3 | 1.83 % | $ 214 M | USA |
 |
Inogen
INGN
|
106 M | $ 6.42 | -0.54 % | $ 171 M | USA |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
LENSAR
LNSR
|
83.7 M | $ 6.07 | 2.45 % | $ 72.6 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
730 M | $ 95.6 | 2.82 % | $ 12.9 B | USA |
 |
Helius Medical Technologies
HSDT
|
5.34 M | $ 1.99 | -1.97 % | $ 1.21 M | USA |
 |
Butterfly Network
BFLY
|
87.2 M | $ 4.43 | 3.62 % | $ 938 M | USA |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
OrthoPediatrics Corp.
KIDS
|
162 M | $ 17.74 | 4.63 % | $ 416 M | USA |
 |
Delcath Systems
DCTH
|
12.4 M | $ 10.79 | 3.25 % | $ 387 M | USA |
 |
Myomo
MYO
|
27.2 M | $ 0.77 | 4.83 % | $ 32.2 M | USA |
 |
Inspire Medical Systems
INSP
|
126 M | $ 56.09 | 2.2 % | $ 1.65 B | USA |
 |
CONMED Corporation
CNMD
|
1.29 B | $ 39.43 | 2.52 % | $ 1.22 B | USA |
 |
LivaNova PLC
LIVN
|
1.41 B | $ 65.33 | 1.16 % | $ 3.56 B |  Britain |
 |
Integer Holdings Corporation
ITGR
|
1.66 B | $ 88.62 | 1.01 % | $ 3.08 B | USA |
 |
FONAR Corporation
FONR
|
53.1 M | $ 18.76 | 0.27 % | $ 123 M | USA |
 |
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 77.69 | -0.56 % | $ 45.4 B | USA |